Parkinson's disease
Parkinson's disease is a recognisable clinical syndrome with a range of causes and clinical
presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; …
presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; …
Parkinson's disease
Parkinson's disease is a neurological disorder with evolving layers of complexity. It has long
been characterised by the classical motor features of parkinsonism associated with Lewy …
been characterised by the classical motor features of parkinsonism associated with Lewy …
Parkinson's disease
A Samii, JG Nutt, BR Ransom - The Lancet, 2004 - thelancet.com
Parkinson's disease is the most common serious movement disorder in the world, affecting
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …
Parkinson's disease
D Burch, F Sheerin - The Lancet, 2005 - thelancet.com
Parkinson's disease is a movement disorder that mainly affects those of middle to old age. It
is progressive over many decades and is characterised by bradykinesia, resting tremor …
is progressive over many decades and is characterised by bradykinesia, resting tremor …
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri, DG Healy, AHV Schapira - The Lancet Neurology, 2006 - thelancet.com
The clinical diagnosis of Parkinson's disease rests on the identification of the characteristics
related to dopamine deficiency that are a consequence of degeneration of the substantia …
related to dopamine deficiency that are a consequence of degeneration of the substantia …
Challenges of modifying disease progression in prediagnostic Parkinson's disease
D Salat, AJ Noyce, A Schrag, E Tolosa - The Lancet Neurology, 2016 - thelancet.com
Neurodegeneration in Parkinson's disease starts years before a clinical diagnosis can be
reliably made. The prediagnostic phase of the disease offers a window of opportunity in …
reliably made. The prediagnostic phase of the disease offers a window of opportunity in …
The burden of Parkinson's disease: a worldwide perspective
WA Rocca - The Lancet Neurology, 2018 - thelancet.com
Over history, diseases have appeared and disappeared, or have increased or decreased in
frequency. These epidemiological trends have occurred more dramatically for infectious …
frequency. These epidemiological trends have occurred more dramatically for infectious …
Epidemiology of Parkinson's disease
LML De Lau, MMB Breteler - The Lancet Neurology, 2006 - thelancet.com
The causes of Parkinson's disease (PD), the second most common neurodegenerative
disorder, are still largely unknown. Current thinking is that major gene mutations cause only …
disorder, are still largely unknown. Current thinking is that major gene mutations cause only …
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Debate is ongoing regarding when, why, and how to initiate pharmacotherapy for
Parkinson's disease. Early initiation of dopaminergic therapies does not convey disease …
Parkinson's disease. Early initiation of dopaminergic therapies does not convey disease …
The epidemiology of Parkinson's disease: risk factors and prevention
A Ascherio, MA Schwarzschild - The Lancet Neurology, 2016 - thelancet.com
Since 2006, several longitudinal studies have assessed environmental or behavioural
factors that seem to modify the risk of developing Parkinson's disease. Increased risk of …
factors that seem to modify the risk of developing Parkinson's disease. Increased risk of …